Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
Background: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carc...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00752/full |
id |
doaj-13e4470899aa4bb2b3ec2eebe49d983d |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yadi Yang Xiaoshan Lin Jing Li Lujun Han Zhipeng Li Shiliang Liu Gangqiang Hou Chuanmiao Xie Xiaofei Lv Yingwei Qiu |
spellingShingle |
Yadi Yang Xiaoshan Lin Jing Li Lujun Han Zhipeng Li Shiliang Liu Gangqiang Hou Chuanmiao Xie Xiaofei Lv Yingwei Qiu Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma Frontiers in Neurology radiotherapy radiation-induced injury regional homogeneity resting-state fMRI nasopharyngeal carcinoma neurocognitive dysfunction |
author_facet |
Yadi Yang Xiaoshan Lin Jing Li Lujun Han Zhipeng Li Shiliang Liu Gangqiang Hou Chuanmiao Xie Xiaofei Lv Yingwei Qiu |
author_sort |
Yadi Yang |
title |
Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma |
title_short |
Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma |
title_full |
Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma |
title_fullStr |
Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma |
title_full_unstemmed |
Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma |
title_sort |
aberrant brain activity at early delay stage post-radiotherapy as a biomarker for predicting neurocognitive dysfunction late-delayed in patients with nasopharyngeal carcinoma |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neurology |
issn |
1664-2295 |
publishDate |
2019-07-01 |
description |
Background: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carcinoma (NPC) patients and to determine whether early abnormal brain activity can predict late neurocognitive dysfunction after RT.Methods: Thirty-three NPC patients were finally included and longitudinally followed up at the following time points: prior to treatment initiation, early-delayed stage (EDS, 1–3 months), and LDS (six months) after RT. Fifteen comparable healthy controls (HCs) were finally included and followed up in parallel. Montreal Cognitive Assessment (MoCA) was used to assess the general cognitive function. Brain activity was recorded via resting-state fMRI and regional homogeneity (ReHo). A whole-brain voxel-wise-based one-way repeated-measure analysis of variance (ANOVA) was conducted to evaluate the longitudinal ReHo changes among the three time points for NPC patients and HCs, respectively. Results were reported at the significant level of a threshold of two-tailed voxel-wise P < 0.01 and cluster level P < 0.05 with Gaussian Random Field (GRF) correction. Finally, the efficacies of the aberrant ReHo at EDS for predicting the cognitive impairment at LDS in NPC patients were evaluated.Results: Significant differences were detected in ReHo among the three time points in NPC patients but not in HCs. Aberrant ReHo was distributed in the bilateral cerebellum, the right temporal lobe, and the left insular areas, which showed different dynamic changes patterns over time. Logistic regression model combining the mean ReHo, age, and irradiation dose on the bilateral temporal lobe had the highest diagnostic efficiency according to the area under the curve (AUC) score (AUC = 0.752, P = 0.023).Conclusions: The post-RT brain activity revealed by ReHo in NPC patients was dynamic, complex, and multifactorial. Furthermore, the combination of the aberrant ReHo at EDS, age, and irradiation dose may serve as a potential biomarker of the RT-induced cognitive impairments at LDS. |
topic |
radiotherapy radiation-induced injury regional homogeneity resting-state fMRI nasopharyngeal carcinoma neurocognitive dysfunction |
url |
https://www.frontiersin.org/article/10.3389/fneur.2019.00752/full |
work_keys_str_mv |
AT yadiyang aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT xiaoshanlin aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT jingli aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT lujunhan aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT zhipengli aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT shiliangliu aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT gangqianghou aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT chuanmiaoxie aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT xiaofeilv aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma AT yingweiqiu aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma |
_version_ |
1725154505572483072 |
spelling |
doaj-13e4470899aa4bb2b3ec2eebe49d983d2020-11-25T01:15:04ZengFrontiers Media S.A.Frontiers in Neurology1664-22952019-07-011010.3389/fneur.2019.00752463107Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal CarcinomaYadi Yang0Xiaoshan Lin1Jing Li2Lujun Han3Zhipeng Li4Shiliang Liu5Gangqiang Hou6Chuanmiao Xie7Xiaofei Lv8Yingwei Qiu9Department of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Radiology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaShenzhen Kangning Hospital, Shenzhen Mental Health Center, Shenzhen, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Radiology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaBackground: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carcinoma (NPC) patients and to determine whether early abnormal brain activity can predict late neurocognitive dysfunction after RT.Methods: Thirty-three NPC patients were finally included and longitudinally followed up at the following time points: prior to treatment initiation, early-delayed stage (EDS, 1–3 months), and LDS (six months) after RT. Fifteen comparable healthy controls (HCs) were finally included and followed up in parallel. Montreal Cognitive Assessment (MoCA) was used to assess the general cognitive function. Brain activity was recorded via resting-state fMRI and regional homogeneity (ReHo). A whole-brain voxel-wise-based one-way repeated-measure analysis of variance (ANOVA) was conducted to evaluate the longitudinal ReHo changes among the three time points for NPC patients and HCs, respectively. Results were reported at the significant level of a threshold of two-tailed voxel-wise P < 0.01 and cluster level P < 0.05 with Gaussian Random Field (GRF) correction. Finally, the efficacies of the aberrant ReHo at EDS for predicting the cognitive impairment at LDS in NPC patients were evaluated.Results: Significant differences were detected in ReHo among the three time points in NPC patients but not in HCs. Aberrant ReHo was distributed in the bilateral cerebellum, the right temporal lobe, and the left insular areas, which showed different dynamic changes patterns over time. Logistic regression model combining the mean ReHo, age, and irradiation dose on the bilateral temporal lobe had the highest diagnostic efficiency according to the area under the curve (AUC) score (AUC = 0.752, P = 0.023).Conclusions: The post-RT brain activity revealed by ReHo in NPC patients was dynamic, complex, and multifactorial. Furthermore, the combination of the aberrant ReHo at EDS, age, and irradiation dose may serve as a potential biomarker of the RT-induced cognitive impairments at LDS.https://www.frontiersin.org/article/10.3389/fneur.2019.00752/fullradiotherapyradiation-induced injuryregional homogeneityresting-state fMRInasopharyngeal carcinomaneurocognitive dysfunction |